Showing results (111-120 of 158) with videos related to
Sort By:
Pageof 16
Multiple Sclerosis and Related Disorders|May 28, 2023
Effects of baseline age and disease duration on the efficacy and safety of siponimod in patients with active SPMS: Post hoc analyses from the EXPAND studyLe H Hua, Amit Bar-Or, Stanley L Cohan, et al.Brain : a Journal of Neurology|November 26, 2025
Cognition in multiple sclerosis within the modern diagnostic and treatment eraJames F Sumowski, Sarah Levy, Ilana Katz Sand, et al.Journal of Interferon Research|October 1, 1993
Systemic recombinant human interferon-beta treatment of relapsing-remitting multiple sclerosis: pilot study analysis and six-year follow-upR L Knobler, J I Greenstein, K P Johnson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 16, 2022
Evaluation of neurotrophic factor secreting mesenchymal stem cells in progressive multiple sclerosisJeffrey A Cohen, Fred D Lublin, Christoper Lock, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 15, 2018
Open-label, add-on trial of cetirizine for neuromyelitis opticaIlana Katz Sand, Michelle T Fabian, Russell Telford, et al.The Lancet. Neurology|February 10, 2009
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) studyEva Havrdova, Steven Galetta, Michael Hutchinson, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 23, 2020
Hippocampal volume is more related to patient-reported memory than objective memory performance in early multiple sclerosisLisa Glukhovsky, Rachel Brandstadter, Victoria M Leavitt, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2010
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksS A Morrow, P W O'Connor, C H Polman, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|November 16, 2020
Depression and cognitive function in early multiple sclerosis: Multitasking is more sensitive than traditional assessmentsLisa Glukhovsky, Daniel Kurz, Rachel Brandstadter, et al.Journal of Neurology|July 16, 2013
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid usePaul W O'Connor, Fred D Lublin, Jerry S Wolinsky, et al.Pageof 16